BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24989269)

  • 1. [Significance of CD37 expression in malignant B cells].
    Wang W; Li Y; Gao L; Xu SH; Gong M; Huang FZ; Li ZL; Chen YR; Ma YG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):644-7. PubMed ID: 24989269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia-associated changes identified by quantitative flow cytometry. III. B-cell gating in CD37/kappa/lambda clonality test.
    Peters RE; Janossy G; Ivory K; al-Ismail S; Mercolino T
    Leukemia; 1994 Nov; 8(11):1864-70. PubMed ID: 7967732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody-Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML.
    Pereira DS; Guevara CI; Jin L; Mbong N; Verlinsky A; Hsu SJ; Aviña H; Karki S; Abad JD; Yang P; Moon SJ; Malik F; Choi MY; An Z; Morrison K; Challita-Eid PM; Doñate F; Joseph IB; Kipps TJ; Dick JE; Stover DR
    Mol Cancer Ther; 2015 Jul; 14(7):1650-60. PubMed ID: 25934707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD37 in B Cell Derived Tumors-More than Just a Docking Point for Monoclonal Antibodies.
    Bobrowicz M; Kubacz M; Slusarczyk A; Winiarska M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
    Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
    Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD37 expression in follicular lymphoma.
    Yoshimura T; Miyoshi H; Shimono J; Nakashima K; Takeuchi M; Yanagida E; Yamada K; Shimasaki Y; Moritsubo M; Furuta T; Kohno K; Ohshima K
    Ann Hematol; 2022 May; 101(5):1067-1075. PubMed ID: 35171311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin's lymphoma.
    Bedewy AM; Elgammal MM; Bedewy MM; El-Maghraby SM
    Ann Hematol; 2013 Oct; 92(10):1359-67. PubMed ID: 23652586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma].
    Sun XF; He LR; Feng HL; Yan SL; Xia ZJ; Chen XQ
    Ai Zheng; 2003 Nov; 22(11):1232-6. PubMed ID: 14613660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoma discrimination by computerized triple matrix analysis of list mode data from three-color flow cytometric immunophenotypes of bone marrow aspirates.
    Bartsch R; Arland M; Lange S; Kahl C; Valet G; Höffkes HG
    Cytometry; 2000 Sep; 41(1):9-18. PubMed ID: 10942891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetraspanin CD37 protects against the development of B cell lymphoma.
    de Winde CM; Veenbergen S; Young KH; Xu-Monette ZY; Wang XX; Xia Y; Jabbar KJ; van den Brand M; van der Schaaf A; Elfrink S; van Houdt IS; Gijbels MJ; van de Loo FA; Bennink MB; Hebeda KM; Groenen PJ; van Krieken JH; Figdor CG; van Spriel AB
    J Clin Invest; 2016 Feb; 126(2):653-66. PubMed ID: 26784544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigational therapies targeting CD37 for the treatment of B-cell lymphoid malignancies.
    Witkowska M; Smolewski P; Robak T
    Expert Opin Investig Drugs; 2018 Feb; 27(2):171-177. PubMed ID: 29323537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multispectral imaging reveals the tissue distribution of tetraspanins in human lymphoid organs.
    de Winde CM; Zuidscherwoude M; Vasaturo A; van der Schaaf A; Figdor CG; van Spriel AB
    Histochem Cell Biol; 2015 Aug; 144(2):133-46. PubMed ID: 25952155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
    Veltroni M; De Zen L; Sanzari MC; Maglia O; Dworzak MN; Ratei R; Biondi A; Basso G; Gaipa G;
    Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiparameter flow cytometric evaluation of bone marrow involvement in B cell non-Hodgkin's lymphoma].
    Wan SG; Sun XJ; Hui WH; He JJ; Liu CY; Zhao H; Sun WL; Su L; Xu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):473-6. PubMed ID: 20416192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD37 targeted immunotherapy of B-Cell malignancies.
    Payandeh Z; Noori E; Khalesi B; Mard-Soltani M; Abdolalizadeh J; Khalili S
    Biotechnol Lett; 2018 Dec; 40(11-12):1459-1466. PubMed ID: 30293139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma.
    Elfrink S; Ter Beest M; Janssen L; Baltissen MP; Jansen PWTC; Kenyon AN; Steen RM; de Windt D; Hagemann PM; Hess C; van Spronsen DJ; Hoevenaars B; van der Spek E; Xu-Monette ZY; Young KH; Kaffa C; Bervoets S; van Heek J; Hesius E; de Winde CM; Vermeulen M; van den Brand M; Scheijen B; van Spriel AB
    Blood Adv; 2022 Apr; 6(7):2254-2266. PubMed ID: 35086136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
    Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
    Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of bone marrow involvement by lymphoma cells in patients with B-NHL by using flow cytometry analysis].
    Wang W; Gao L; Wang LL; Li MY; Li YY; Zhao W; Xu YY; Ding Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1204-7. PubMed ID: 21129261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL).
    Perea G; Altés A; Bellido M; Aventín A; Bordes R; Ayats R; Remacha AF; Espinosa I; Briones J; Sierra J; Nomdedéu JF
    Histopathology; 2004 Sep; 45(3):268-74. PubMed ID: 15330805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.